Search Results 1531-1540 of 16363 for alt

  1. Intravenous Ketamine For Treatment-Resistant Depression - Mayo Clinic

    * Hepatic insufficiency (2.5 X ULN for AST or ALT) within 1 year of consent, past liver transplant recipient, and/or clinical diagnosis of cirrhosis of the ...

  2. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ALT, AST, or ALP ≥ 2.5 x upper limit of normal (ULN), total bilirubin ≥ 2 x ULN, or presence of abnormalities in synthetic liver function tests judged to ...

  3. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    ... (ALT) (serum glutamic pyruvic transaminase [SGPT]) =< 2.5 X ULN unless liver metastases are present, in which case it must be =< 5 x ULN (=< 14 days prior to ...

  4. A Study to Evaluate HH2853 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors - Mayo Clinic

    AST/SGOT and ALT/SGPT ≤ 2.5 x ULN or ≤ 5 x ULN if liver metastases are present 3. 24-hour creatinine clearance (calculated* or measured value**)≥ 50 mL ...

  5. Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) - Mayo Clinic

    Alanine Aminotransferase (ALT) or Aspartate Aminotransferase (AST) ≥ 2.0 times the ULN. 13. Positive COVID-19 PCR test, or alternative nucleic acid ...

  6. Study of VS-6766 + Adagrasib in KRAS G12C NSCLC Patients - Mayo Clinic

    ... (ALT) and aspartate aminotransferase (AST) ≤ 2.5 x ULN (or < 5 x ULN in patients with liver metastases);; Adequate renal function with creatinine clearance ...

  7. Mayo Clinic researchers identify link between gut bacteria and pre-clinical autoimmunity and aging in rheumatoid arthritis

    They published their findings in a recent study in Science Advances. This image has an empty alt attribute; its file name is MSS_0001342127.jpg- Veena ...

  8. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    For subjects with known Gilbert's disease or similar syndrome with slow conjugation of bilirubin, total bilirubin ≤ 3.0 mg/dL AST/ALT ≤3.0 × institutional ...

  9. Testing The Use Of The Combination Of Selumetinib And Olaparib Or Selumetinib Alone Targeted Treatment For RAS Pathway Mutant Recurrent Or Persistent Ovarian And Endometrial Cancers, A ComboMATCH Treatment Trial - Mayo Clinic

    - Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x ULN (within 14 days prior to registration) - Patients must be able to swallow ...

  10. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...